Dune: Part Two, the anticipated follow-up to 2021’s six-time Oscar-winning Dune, was written by Denis Villeneuve and Jon ...

After about five years working behind the scenes, Arrakis Therapeutics is unveiling that its lead program will aim to treat ...

ArrakisTx was formed to create RNA-intercepting drugs to fight cancer. Despite some promising data, CEO @michael_gilman says it will shift targets.

Dune: Prophecy episode 4 reveals that the mysterious Desmond Hart is committed to hunting down and punishing anyone who is ...

The Alliance for Pharmacy Compounding rebutted Novo's FDA petition to bar compounding pharmacies from copying its weight loss ...

"Dune"-inspired Arrakis Therapeutics has tested its spice—an RNA-targeting small molecule—in a mouse model of myotonic ...

The world of Arrakis is yours for the taking, if you can do it with the right resources and pieces of land in the game Risk: ...

Arrakis' oral therapies targeting disease-driving RNA in myotonic dystrophy have shown promise in preclinical studies.

The classic Risk board game is coming to Arrakis. Specifically Denis Villeneuve's vision of Arrakis in his acclaimed movie series starring Timothée Chalamet as Paul Atreides.

Part Two” “was bigger” and “more intense” than the first film, with “way more action sequences.” For instance, “on the first ...

The sisters have a terrifying vision. Desmond gives a terrifying display of his power and loyalty. Any connection?

The already expansive “Dune” universe is about to get even bigger, “Dune: Prophecy” executive producer Alison Schapker tells ...